Bone Marrow Transplantation

Top Story

Lymphoma survivors face increased risk for cardiac problems after HSCT

July 29, 2015

Left ventricular systolic dysfunction and heart failure occurred more frequently than previously reported in adult survivors of lymphoma who underwent autologous hematopoietic stem cell transplantation, according to study results.

Researchers identified several risk factors for left ventricular systolic dysfunction (LVSD) in this population, which could serve as a basis for targeted surveillance.

In the Journals

Fever present in HHV-6 reactivation after pediatric stem cell transplant

July 22, 2015
The reactivation of human herpesvirus-6 after pediatric allogenic stem cell transplantation may explain the previously unknown origin of fever in 30% of patients…
In the Journals

Algorithm may improve reporting of mortality after allogeneic HSCT

July 16, 2015
The review and adjudication of cause-specific deaths within 1 year after allogeneic hematopoietic stem cell transplantation has led to the development of definitions…
Ran Reshef, MD In the Journals

Higher CD8 T-cell dose from younger donors improves allogeneic HSCT outcomes

July 2, 2015
A higher graft CD8 dose from younger donors — even if they are not related to the patient — predicted improved survival in patients with hematologic…
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
Meeting News Coverage Video
4131355725001 th

CD19-targeted T-cells show potential in B-ALL, allogeneic stem cell transplantation

June 19, 2014
CHICAGO — Eunice Wang, MD, associate professor in the department of medicine at Roswell Park Cancer Institute…
More »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
In the Journals

Lymphoma survivors face increased risk for cardiac problems after HSCT

July 29, 2015
Left ventricular systolic dysfunction and heart failure occurred more frequently than previously reported in adult survivors of lymphoma who…
In the Journals

Fever present in HHV-6 reactivation after pediatric stem cell transplant

July 22, 2015
The reactivation of human herpesvirus-6 after pediatric allogenic stem cell transplantation may explain the previously unknown origin of fever in 30%…
In the Journals

Algorithm may improve reporting of mortality after allogeneic HSCT

July 16, 2015
The review and adjudication of cause-specific deaths within 1 year after allogeneic hematopoietic stem cell transplantation has led to the…
Ran Reshef, MD In the Journals

Higher CD8 T-cell dose from younger donors improves allogeneic HSCT outcomes

July 2, 2015
A higher graft CD8 dose from younger donors — even if they are not related to the patient — predicted improved survival in patients with…
In the Journals

HSCT improves survival for older patients with multiple myeloma

June 30, 2015
Hematopoietic stem cell transplantation improved OS for elderly patients with multiple myeloma in the real-world setting, according to results of a…
In the Journals

Graft-versus-host disease causes enteric bacterial BSI in children after HCT

May 19, 2015
Acute gastrointestinal graft-versus-host disease is likely to cause greater enteric bacterial bloodstream infection density in children who have…
In the Journals

Gene therapy effectively treats complications of Wiskott-Aldrich syndrome in children

May 18, 2015
In a small cohort of children and adolescents with Wiskott-Aldrich syndrome, autologous hematopoietic stem cell gene therapy led to clinical…
Stephen D. Nimer, MD Industry News

Cancer center director receives award from Bone Marrow Foundation

May 17, 2015
Stephen D. Nimer, MD, director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, received the Dr. E…
VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder Meeting News CoverageVideo

VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder

April 27, 2015
Richard J. O’Reilly, MD, chairman of the department of pediatrics at Memorial Sloan Kettering Cancer Center, provides an overview of trials…
Hemant Murthy, MD In PracticePublication Exclusive

State of the science: High-priority transplant trials for nonmalignant disease

HemOnc Today, April 25, 2015
Hemant Murthy, MD; William Wood, MD
Last June, we launched a series of columns in HemOnc Today intended to discuss high-priority proposals that emerged from the 2014 Blood and Marrow…
More Headlines »
morganatic-roan